High-sensitivity clonal hematopoiesis assay
November 10, 2026
For patients with cancer, genetic mutations present at low levels in the blood can be susceptible to expansion into hematologic malignancies under the selective pressure of treatment. High-sensitivity clonal hematopoiesis testing can reveal these emerging clones earlier, providing information that may help guide risk assessment, treatment planning, and longitudinal monitoring.